Heartland Advisors Inc. increased its position in Teleflex Incorporated (NYSE:TFX – Free Report) by 3.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 218,773 shares of the medical technology company’s stock after purchasing an additional 6,925 shares during the quarter. Teleflex makes up 1.3% of Heartland Advisors Inc.’s portfolio, making the stock its 7th biggest position. Heartland Advisors Inc. owned 0.55% of Teleflex worth $27,355,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Kelleher Financial Advisors acquired a new position in Teleflex during the 2nd quarter valued at about $25,000. Root Financial Partners LLC bought a new position in shares of Teleflex in the 3rd quarter valued at about $27,000. Next Level Wealth Planning LLC acquired a new stake in shares of Teleflex during the 3rd quarter worth approximately $38,000. Heritage Family Offices LLP acquired a new stake in shares of Teleflex during the 3rd quarter worth approximately $39,000. Finally, Allworth Financial LP acquired a new stake in shares of Teleflex during the 2nd quarter worth approximately $44,000. 95.62% of the stock is owned by institutional investors.
Teleflex Price Performance
Shares of TFX opened at $165.54 on Thursday. The company has a current ratio of 2.01, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $166.75. The stock has a market cap of $6.57 billion, a P/E ratio of 20.10, a price-to-earnings-growth ratio of 1.07 and a beta of 0.85. The stock’s 50-day moving average price is $135.04 and its two-hundred day moving average price is $128.21.
Teleflex (NYSE:TFX – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The medical technology company reported $2.63 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.73. The company had revenue of $567.80 million during the quarter, compared to analysts’ expectations of $565.52 million. Teleflex had a return on equity of 10.57% and a net margin of 13.51%. Teleflex’s revenue was up .1% on a year-over-year basis. During the same period in the prior year, the business posted $3.67 EPS. On average, equities analysts predict that Teleflex Incorporated will post 7.67 earnings per share for the current year.
Teleflex Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 31st. Investors of record on Monday, November 16th will be issued a dividend of $0.34 per share. The ex-dividend date is Monday, November 16th. This represents a $1.36 dividend on an annualized basis and a yield of 0.8%. Teleflex’s payout ratio is currently 16.52%.
Analyst Ratings Changes
Several equities analysts recently weighed in on TFX shares. Mizuho set a $160.00 price objective on shares of Teleflex in a report on Friday, November 6th. Piper Sandler reaffirmed an “overweight” rating and issued a $169.00 price objective (up from $160.00) on shares of Teleflex in a research note on Friday, August 7th. Wall Street Zen raised shares of Teleflex from a “hold” rating to a “buy” rating in a report on Saturday, November 7th. Royal Bank Of Canada upped their target price on shares of Teleflex from $155.00 to $175.00 and gave the company an “outperform” rating in a research report on Friday, November 6th. Finally, Weiss Ratings raised Teleflex from a “sell (d)” rating to a “hold (c)” rating in a research note on Monday, November 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $163.30.
Check Out Our Latest Research Report on Teleflex
Teleflex Company Profile
Teleflex is a global medical technology company that develops, manufactures and markets single-use medical devices used by healthcare professionals in hospitals and other care settings. Its products support a range of procedures, including vascular access, anesthesia, critical care, surgery, urology and emergency medicine. The company’s offerings include vascular and interventional access devices, catheters, airway management products, surgical instruments and other devices used in diagnostic and therapeutic procedures.
Recommended Stories
- Five stocks we like better than Teleflex
- Lowe’s Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the Math
- Grounded at 52-Week Lows: When Will Boeing Stock Take Flight?
- Apple’s Next Margin Defense Could Be Hiding in Your Wallet
- From Berlin to Brussels: Tesla’s $3.3 Billion Robotaxi Gamble
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
